Tom Williams/Lancet Haematol
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Aygun B
Lane A
Smart LR
Santos B
Tshilolo L
Williams TN
Olupot-Olupot P
Stuber SE
Tomlinson G
Latham T
Ware RE
Reach Investigators
Lancet Haematol, (2024). 11:e425-e435
Filling the data gaps on sickle cell anaemia in sub-Saharan Africa.Williams TN
Lancet Haematol, (2022). 9:e172-e173
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study.Ndila CM
Uyoga S
Macharia AW
Nyutu G
Peshu N
Ojal J
Shebe M
Awuondo KO
Mturi N
Tsofa B
Sepulveda N
Clark TG
Band G
Clarke G
Rowlands K
Hubbart C
Jeffreys A
Kariuki S
Marsh K
Mackinnon M
Maitland K
Kwiatkowski DP
Rockett KA
Williams TN
Malaria GENConsortium
Lancet Haematol, (2018). 5:e333-e345
Red blood cell variants and malaria: a long story not yet over.Williams TN
Lancet Haematol, (2015). 2:e130-1
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.Uyoga S
Ndila CM
Macharia AW
Nyutu G
Shah S
Peshu N
Clarke GM
Kwiatkowski DP
Rockett KA
Williams TN
Malaria GENConsortium
Lancet Haematol, (2015). 2:e437-44
Managing the burden of sickle-cell disease in Africa.Piel FB
Rees DC
Williams TN
Lancet Haematol, (2014). 1:e11-2
